Abstract
New sildenafil analogues with an N-acylamido group at the 5′-position of the phenyl ring, 6a-e, were prepared from the readily available starting compound 2 in four straightforward steps. Enzyme assays demonstrated that all the target compounds 6a-e showed higher PDE5 inhibitory activities than sildenafil. It was observed that the PDE5 inhibitory activity was enhanced as the chain length of R group increased, but introduction of the branched alkyl groups such as isopropyl (6d) and cyclohexyl (6e) resulted in the drop of potency compared with 6c. In particular the N-butyrylamido derivative 6c exhibited the highest PDE5 inhibitory activity, and was about 6-fold more potent than sildenafil. However, all the compounds exhibited somewhat weak selectivity (1-3-fold) over PDE6, indicating that the compounds 6a-e have intrinsically lower selectivity than sildenafil.
| Original language | English |
|---|---|
| Pages (from-to) | 1895-1899 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry |
| Volume | 9 |
| Issue number | 7 |
| DOIs | |
| State | Published - 2001 |
Fingerprint
Dive into the research topics of 'Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1, 6-dihydro-7H-pyrazolo[4, 3-d]pyrimidin-7-one derivatives containing an N-acylamido group on a phenyl ring'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver